title: Case report: verapamil-induced subacute cutaneous lupus erythematosus.
abstract: Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, are one of the most widely prescribed class of drugs in the treatment of cardiovascular disease. In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.
authors: Department of Medicine, St. Luke's-Roosevelt Hospital Center, New York, NY, USA.
authors: Boaz
authors: B
authors: Kurtis
authors: Matthew J
authors: MJ
authors: Larson
authors: Mai P
authors: MP
authors: Hoang
authors: Jack B
authors: JB
authors: Cohen
mesh_terms: D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000473:pathology*; D008875:Middle Aged; D014700:Verapamil / Q000009:adverse effects*
chemical_list: D014700:Verapamil